Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction.
Anthony V MoormanAmir EnshaeiDaniel MurdyMelvin JoyJudith M BoerMonique L Den BoerRob PietersValerie de HaasMartin A HorstmannGabriele EscherichBertil JohanssonHanne Vibeke Hansen MarquartKjeld SchmiegelowJeremy HancockJohn P MoppettMats HeymanPublished in: Leukemia (2024)